Both in Pharmaceuticals
Mannkind vs LB Pharmaceuticals
Over the past year MNKD returned −44.6% and LBRX returned +145.2%; their daily moves had a correlation of 0.13.
MNKD −44.6% LBRX +145.2%Growth of $1, one year, split-adjusted
| Metric | MNKD | LBRX |
|---|---|---|
| Price | $3.05 | $39.23 |
| Market cap | $980.7M | $1.27B |
| Today | −1.61% | −4.32% |
| 1 month | −12.6% | −8.1% |
| 6 months | +11.3% | +23.4% |
| Year to date | −46.2% | +76.2% |
| 1 year | −44.4% | +145.2% |
| Revenue growth (YoY) | +42.9% | — |
| Gross margin | 73.0% | — |
| Net margin | −17.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.5× | — |
| Net cash | -$373.9M | $327.8M |
| Dividend yield | — | — |
| Volatility (60d) | 60.2% | 61.2% |
| Short % of float | 8.4% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).